Skip to main content
×
×
Home

Functional outcome after long-term low-dose trimethoprim/sulfamethoxazole in chronic rhinosinusitis with purulence: a prospective study

  • G de Bonnecaze (a1), B Chaput (a2), A Dupret-Bories (a3), S Vergez (a1) (a3) and E Serrano (a1)...
Abstract
Objective

Trimethoprim/sulfamethoxazole has been suggested as a treatment option for chronic rhinosinusitis with purulence. This study aimed to assess the functional and endoscopic outcomes after a three-month course of low-dose trimethoprim/sulfamethoxazole.

Methods

A prospective study was performed, comprising patients referred to a tertiary care medical centre with a diagnosis of chronic rhinosinusitis with purulence. Trimethoprim/sulfamethoxazole was prescribed at 960 mg/day for three months. Sinonasal complaints and endoscopic findings were documented, and bacteriological data were compared.

Results

Fifteen patients were included. Staphylococcus aureus was the most common bacterium cultured (86 per cent). Improvement in nasal function, as measured by the 22-item Sino-Nasal Outcome Test, was highly significant at three months (p < 0.0005). This improvement slightly decreased but remained significant at 6, 9 and 12 months. No side effects were noted. Endoscopic scores revealed similar and concordant improvements.

Conclusion

Long-term low-dose trimethoprim/sulfamethoxazole therapy seems to be a safe option for selected patients. Additional randomised multicentre studies remain necessary.

Copyright
Corresponding author
Address for correspondence: Dr Guillaume de Bonnecaze, 24 Chemin de Pouvourville, 31059 Toulouse, France E-mail: guidb31@yahoo.fr
Footnotes
Hide All

Dr G de Bonnecaze takes responsibility for the integrity of the content of the paper

Footnotes
References
Hide All
1Fokkens, WJ, Lund, VJ, Mullol, J, Bachert, C, Alobid, I, Baroody, F et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012;3:1298
2Hellings, PW, Fokkens, WJ, Akdis, C, Bachert, C, Cingi, C, Dietz de Loos, D et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2013;68:17
3Videler, WJ, van Hee, K, Reinartz, SM, Georgalas, C, van der Meulen, FW, Fokkens, WJ. Long-term low-dose antibiotics in recalcitrant chronic rhinosinusitis: a retrospective analysis. Rhinology 2012;50:4555
4Cervin, A, Wallwork, B. Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep 2014;14:416–22
5Piromchai, P, Thanaviratananich, S, Laopaiboon, M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database Syst Rev 2011;(5):CD008233
6de Dorlodot, C, Horoi, M, Lefebvre, P, Collet, S, Bertrand, B, Eloy, P et al. French adaptation and validation of the sino-nasal outcome test-22: a prospective cohort study on quality of life among 422 subjects. Clin Otolaryngol 2015;40:2935
7Rott, O, Mignon-Godefroy, K, Fleischer, B, Charreire, J, Cash, E. Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation. Cell Immunol 1995;161:158–65
8Khalid, AN, Hunt, J, Perloff, JR, Kennedy, DW. The role of bone in chronic rhinosinusitis. Laryngoscope 2002;112:1951–7
9Davis, LJ, Kita, H. Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin North Am 2004;24:5973
10Post, JC, Stoodley, P, Hall-Stoodley, L, Ehrlich, GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg 2004;12:185–90
11Pynnonen, MA, Venkatraman, G, Davis, GE. Macrolide therapy for chronic rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg 2013;148:366–73
12Cervin, A, Kalm, O, Sandkull, P, Lindberg, S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002;126:481–9
13Hashiba, M, Baba, S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996;525:73–8
14Wallwork, B, Coman, W, Mackay-Sim, A, Greiff, L, Cervin, A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006;116:189–93
15Videler, WJ, Badia, L, Harvey, RJ, Gane, S, Georgalas, C, van der Meulen, FW et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011;66:1457–68
16Van Zele, T, Gevaert, P, Holtappels, G, Beule, A, Wormald, PJ, Mayr, S et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010;125:1069–76
17Yoshihara, S, Kondo, K, Kanaya, K, Suzukawa, K, Baba, S, Toma-Hirano, M et al. Tumour necrosis factor inhibitor-associated sinusitis. Rhinology 2014;52:246–51
18Harvey, RJ, Wallwork, BD, Lund, VJ. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin North Am 2009;29:689703
19Chalermwatanachai, T, Velásquez, LC, Bachert, C. The microbiome of the upper airways: focus on chronic rhinosinusitis. World Allergy Organ J 2015;8:3
20Desrosiers, MY, Salas-Prato, M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001;125:265–9
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed